DermaSensor is more than technology; it is a commitment to helping physicians detect skin cancer at the point of care with the first AI-powered medical device for all three common skin cancers.
Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.